Showing results (141-150 of 203) with videos related to
Sort By:
Pageof 21
The Journal of Clinical Investigation|October 1, 1985
Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexateG A Curt, J Jolivet, D N Carney, et al.Annals of Internal Medicine|March 1, 1983
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapyR I Fisher, V T DeVita, S M Hubbard, et al.Cancer Research|July 1, 1995
Tyrphostin AG17, [(3,5-Di-tert-butyl-4-hydroxybenzylidene)- malononitrile], inhibits cell growth by disrupting mitochondriaA M Burger, G Kaur, M C Alley, et al.Cancer|December 15, 1982
Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer InstituteT Anderson, B A Chabner, R C Young, et al.The Oncologist|May 5, 2000
Communicating genetic risk: pros, cons, and counselR T Penson, M V Seiden, K M Shannon, et al.The Cancer Journal From Scientific American|January 1, 1996
Antiproliferative effect in vitro and antitumor activity in vivo of brefeldin AE A Sausville, K L Duncan, A Senderowicz, et al.Annals of Internal Medicine|August 1, 1976
Sequential nonsurgical and surgical staging of non-Hodgkin's lymphomaB A Chabner, R E Johnson, R C Young, et al.Experimental Hematology|May 30, 2001
UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanismJ C Byrd, C Shinn, C R Willis, et al.The Journal of Infectious Diseases|May 1, 1987
Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondiiJ A Kovacs, C J Allegra, B A Chabner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCHM Gutierrez, B A Chabner, D Pearson, et al.Pageof 21